Cargando…

Correction: METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation

Detalles Bibliográficos
Autores principales: Lin, Chengjie, Li, Ting, Wang, Yan, Lai, Shihui, Huang, Yue, Guo, Zhenyun, Zhang, Xiang, Weng, Shangeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390565/
https://www.ncbi.nlm.nih.gov/pubmed/37524717
http://dx.doi.org/10.1038/s41419-023-05939-1
_version_ 1785082504500215808
author Lin, Chengjie
Li, Ting
Wang, Yan
Lai, Shihui
Huang, Yue
Guo, Zhenyun
Zhang, Xiang
Weng, Shangeng
author_facet Lin, Chengjie
Li, Ting
Wang, Yan
Lai, Shihui
Huang, Yue
Guo, Zhenyun
Zhang, Xiang
Weng, Shangeng
author_sort Lin, Chengjie
collection PubMed
description
format Online
Article
Text
id pubmed-10390565
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-103905652023-08-02 Correction: METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation Lin, Chengjie Li, Ting Wang, Yan Lai, Shihui Huang, Yue Guo, Zhenyun Zhang, Xiang Weng, Shangeng Cell Death Dis Correction Nature Publishing Group UK 2023-07-31 /pmc/articles/PMC10390565/ /pubmed/37524717 http://dx.doi.org/10.1038/s41419-023-05939-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Lin, Chengjie
Li, Ting
Wang, Yan
Lai, Shihui
Huang, Yue
Guo, Zhenyun
Zhang, Xiang
Weng, Shangeng
Correction: METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation
title Correction: METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation
title_full Correction: METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation
title_fullStr Correction: METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation
title_full_unstemmed Correction: METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation
title_short Correction: METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation
title_sort correction: mettl3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying ddx23 mrna n6 adenosine methylation
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390565/
https://www.ncbi.nlm.nih.gov/pubmed/37524717
http://dx.doi.org/10.1038/s41419-023-05939-1
work_keys_str_mv AT linchengjie correctionmettl3enhancespancreaticductaladenocarcinomaprogressionandgemcitabineresistancethroughmodifyingddx23mrnan6adenosinemethylation
AT liting correctionmettl3enhancespancreaticductaladenocarcinomaprogressionandgemcitabineresistancethroughmodifyingddx23mrnan6adenosinemethylation
AT wangyan correctionmettl3enhancespancreaticductaladenocarcinomaprogressionandgemcitabineresistancethroughmodifyingddx23mrnan6adenosinemethylation
AT laishihui correctionmettl3enhancespancreaticductaladenocarcinomaprogressionandgemcitabineresistancethroughmodifyingddx23mrnan6adenosinemethylation
AT huangyue correctionmettl3enhancespancreaticductaladenocarcinomaprogressionandgemcitabineresistancethroughmodifyingddx23mrnan6adenosinemethylation
AT guozhenyun correctionmettl3enhancespancreaticductaladenocarcinomaprogressionandgemcitabineresistancethroughmodifyingddx23mrnan6adenosinemethylation
AT zhangxiang correctionmettl3enhancespancreaticductaladenocarcinomaprogressionandgemcitabineresistancethroughmodifyingddx23mrnan6adenosinemethylation
AT wengshangeng correctionmettl3enhancespancreaticductaladenocarcinomaprogressionandgemcitabineresistancethroughmodifyingddx23mrnan6adenosinemethylation